These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 38782984)
21. Protein-centric omics integration analysis identifies candidate plasma proteins for multiple autoimmune diseases. Chen Y; Liu S; Gong W; Guo P; Xue F; Zhou X; Wang S; Yuan Z Hum Genet; 2024 Oct; 143(9-10):1035-1048. PubMed ID: 38143258 [TBL] [Abstract][Full Text] [Related]
22. Causal relationships between neuropsychiatric disorders and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study. Wang S; Gao H; Lin P; Qian T; Xu L BMC Gastroenterol; 2024 Sep; 24(1):299. PubMed ID: 39227758 [TBL] [Abstract][Full Text] [Related]
23. Mendelian randomization suggests a causal relationship between gut microbiota and nonalcoholic fatty liver disease in humans. Dai X; Jiang K; Ma X; Hu H; Mo X; Huang K; Jiang Q; Chen Y; Liu C Medicine (Baltimore); 2024 Mar; 103(12):e37478. PubMed ID: 38518048 [TBL] [Abstract][Full Text] [Related]
24. Role of Inflammatory Factors in Mediating the Effect of Lipids on Nonalcoholic Fatty Liver Disease: A Two-Step, Multivariable Mendelian Randomization Study. Chen J; Zhou H; Jin H; Liu K Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297117 [TBL] [Abstract][Full Text] [Related]
25. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease. Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492 [TBL] [Abstract][Full Text] [Related]
27. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis. Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J Front Immunol; 2024; 15():1366736. PubMed ID: 38566994 [TBL] [Abstract][Full Text] [Related]
28. Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study. Zhao H; Zhou Y; Wang Z; Zhang X; Chen L; Hong Z Front Immunol; 2024; 15():1417564. PubMed ID: 39026678 [TBL] [Abstract][Full Text] [Related]
29. Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study. Tao M; Zhou G; Liu J; He M; Wang C; Luo X; Zhang L Clin Endocrinol (Oxf); 2023 Oct; 99(4):370-377. PubMed ID: 37559547 [TBL] [Abstract][Full Text] [Related]
30. The Impact of Non-alcohol Fatty Liver Disease on Bone Mineral Density is Mediated by Sclerostin by Mendelian Randomization Study. Liu Y; Yuan M; He J; Cai L; Leng A Calcif Tissue Int; 2024 May; 114(5):502-512. PubMed ID: 38555554 [TBL] [Abstract][Full Text] [Related]
31. Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation. Yuan S; Chen J; Dan L; Xie Y; Sun Y; Li X; Larsson SC Am J Clin Nutr; 2022 Dec; 116(6):1595-1609. PubMed ID: 36205540 [TBL] [Abstract][Full Text] [Related]
32. Periodontitis and NAFLD-related diseases: A bidirectional two-sample Mendelian randomization study. Qiao F; Li X; Liu Y; Zhang S; Liu D; Li C Oral Dis; 2024 Jul; 30(5):3452-3461. PubMed ID: 37877540 [TBL] [Abstract][Full Text] [Related]
33. Non-alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study. Liu N; Wang G; Liu C; Liu J; Huang S; Zhou Y; Xiao E Diabetes Obes Metab; 2023 Feb; 25(2):365-376. PubMed ID: 36181433 [TBL] [Abstract][Full Text] [Related]
34. Serum 25-hydroxyvitamin D levels and the risk of non-alcoholic fatty liver: A two-sample Mendelian randomization study. Sheng Q; Shi H; Liu S; Zhuang L; Zhao Z; Xin Y Saudi J Gastroenterol; 2023; 29(1):39-46. PubMed ID: 36254930 [TBL] [Abstract][Full Text] [Related]
35. Integrated analyses of single-cell transcriptome and Mendelian randomization reveal the protective role of FCRL3 in multiple sclerosis. Yu K; Jiang R; Li Z; Ren X; Jiang H; Zhao Z Front Immunol; 2024; 15():1428962. PubMed ID: 39076991 [TBL] [Abstract][Full Text] [Related]
36. Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study. Chen L; Fan Z; Sun X; Qiu W; Mu W; Chai K; Cao Y; Wang G; Lv G Hepatol Int; 2023 Apr; 17(2):326-338. PubMed ID: 36352064 [TBL] [Abstract][Full Text] [Related]
37. Causal effects of female reproductive features on nonalcoholic fatty liver disease: A mendelian randomization study. Fu H; Song S; Du B; Zhou T; Cai M; Jiang S; Chen Y; Zang X; Huang Y; Wang W; Xie Q J Gene Med; 2024 Sep; 26(9):e3738. PubMed ID: 39245705 [TBL] [Abstract][Full Text] [Related]
38. Association between gut microbiota and NAFLD/NASH: a bidirectional two-sample Mendelian randomization study. Zhai Q; Wu H; Zheng S; Zhong T; Du C; Yuan J; Peng J; Cai C; Li J Front Cell Infect Microbiol; 2023; 13():1294826. PubMed ID: 38106475 [TBL] [Abstract][Full Text] [Related]
39. Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study. Peng H; Wang S; Wang M; Ye Y; Xue E; Chen X; Wang X; Fan M; Gao W; Qin X; Wu Y; Chen D; Li J; Hu Y; Wang L; Wu T Metabolism; 2022 Aug; 133():155220. PubMed ID: 35618017 [TBL] [Abstract][Full Text] [Related]
40. Mendelian-randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures. Pei X; Jiang W; Li L; Zeng Q; Liu CH; Wang M; Chen E; Zhou T; Tang H; Wu D J Gastroenterol Hepatol; 2024 May; 39(5):847-857. PubMed ID: 38240493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]